tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
Holding EYPT?
Track your performance easily

EyePoint Pharmaceuticals (EYPT) Financial Statements

824 Followers

EyePoint Pharmaceuticals Financial Overview

EyePoint Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.006; its P/E ratio is -4.46; EyePoint Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 10.52M$ 9.48M$ 11.68M$ 15.20M$ 9.11M
Gross Profit$ 9.79M$ 8.08M$ 10.93M$ 14.00M$ 7.31M
EBIT$ -29.36M$ -30.83M$ -29.28M$ -12.61M$ -22.48M
EBITDA$ -28.95M$ -30.46M$ -28.98M$ -12.50M$ -22.35M
Net Income Common Stockholders$ -29.36M$ -30.83M$ -29.28M$ -12.61M$ -22.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 253.79M$ 280.25M$ 299.35M$ 136.03M$ 142.50M
Total Assets$ 300.92M$ 324.25M$ 329.25M$ 160.04M$ 175.66M
Total Debt$ 21.92M$ 22.16M$ 4.62M$ 5.18M$ 5.46M
Net Debt$ -231.87M$ -258.08M$ -294.72M$ -130.85M$ -137.04M
Total Liabilities$ 82.18M$ 95.94M$ 79.31M$ 101.42M$ 118.39M
Stockholders Equity$ 218.73M$ 228.31M$ 249.93M$ 58.62M$ 57.26M
Cash Flow-
Free Cash Flow$ -40.60M$ -21.08M$ -32.37M$ -16.92M$ 56.63M
Operating Cash Flow$ -39.03M$ -20.18M$ -31.17M$ -15.20M$ 57.02M
Investing Cash Flow$ 16.20M$ -160.40M$ 20.81M$ -1.72M$ 13.47M
Financing Cash Flow$ 11.89M$ 329.00K$ 115.00K$ 10.36M$ -36.66M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

EyePoint Pharmaceuticals Debt to Assets

EyePoint Pharmaceuticals Cash Flow

EyePoint Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis